Matches in Nanopublications for { ?s ?p "[Characterization of amplified regions of the genome in breast cancer has led to the identification of important oncogenes including erbB-2/HER-2, C-MYC, and fibroblast growth factor receptor (FGFR) 2.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 7 of
7
with 100 items per page.
- NP264288.RA7k4oeMeeiVYb515s63In2tthpjIw_ZXCG5i7MmMrMD4130_assertion description "[Characterization of amplified regions of the genome in breast cancer has led to the identification of important oncogenes including erbB-2/HER-2, C-MYC, and fibroblast growth factor receptor (FGFR) 2.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP264288.RA7k4oeMeeiVYb515s63In2tthpjIw_ZXCG5i7MmMrMD4130_provenance.
- assertion description "[Characterization of amplified regions of the genome in breast cancer has led to the identification of important oncogenes including erbB-2/HER-2, C-MYC, and fibroblast growth factor receptor (FGFR) 2.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Characterization of amplified regions of the genome in breast cancer has led to the identification of important oncogenes including erbB-2/HER-2, C-MYC, and fibroblast growth factor receptor (FGFR) 2.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Characterization of amplified regions of the genome in breast cancer has led to the identification of important oncogenes including erbB-2/HER-2, C-MYC, and fibroblast growth factor receptor (FGFR) 2.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Characterization of amplified regions of the genome in breast cancer has led to the identification of important oncogenes including erbB-2/HER-2, C-MYC, and fibroblast growth factor receptor (FGFR) 2.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP428417.RABXgF_JIy0KSuYsFZeftD0N1fWC4esIiH2_z3OidF0mY130_assertion description "[Characterization of amplified regions of the genome in breast cancer has led to the identification of important oncogenes including erbB-2/HER-2, C-MYC, and fibroblast growth factor receptor (FGFR) 2.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP428417.RABXgF_JIy0KSuYsFZeftD0N1fWC4esIiH2_z3OidF0mY130_provenance.
- NP428418.RA2QzEQAB_GLqK84AIFGXefbdWafJ8phEQuSmQhRl1EcQ130_assertion description "[Characterization of amplified regions of the genome in breast cancer has led to the identification of important oncogenes including erbB-2/HER-2, C-MYC, and fibroblast growth factor receptor (FGFR) 2.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP428418.RA2QzEQAB_GLqK84AIFGXefbdWafJ8phEQuSmQhRl1EcQ130_provenance.